• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Blend Labs Inc. filed SEC Form 8-K: Regulation FD Disclosure

    6/9/25 4:05:44 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology
    Get the next $BLND alert in real time by email
    blnd-20250609
    FALSE000185574700018557472025-06-092025-06-09

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    Form 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
     
    Date of Report (date of earliest event reported): June 9, 2025
     
    Blend Labs, Inc.
    (Exact name of Registrant, as specified in its charter)

    Delaware001-4059945-5211045
    (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification Number)
    7250 Redwood Blvd., Suite 300
    Novato, California 94945
    (Address of principal executive offices, including zip code)
    (650) 550-4810
    (Registrant's telephone number, including area code)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 
    Securities registered pursuant to Section 12(b) of the Act:

    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Class A Common Stock, par value of $0.00001 per shareBLNDNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 
    Emerging growth company ☒
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐






    Item 7.01    Regulation FD Disclosure

    On June 9, 2025, Blend Labs, Inc. (the “Company” or “Blend”), announced that it had entered into a definitive agreement to sell its title insurance business, Title365 Holding Co., to Covius Services, LLC. The transaction is subject to certain required third-party consents and regulatory approvals. It is expected to close in the coming months.

    The information in Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing.





    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     Blend Labs, Inc.
    Date: June 9, 2024  
     By:
    /s/ Amir Jafari
     Name:
    Amir Jafari
     Title:
    Head of Finance and Administration
    (Principal Financial Officer)


    Get the next $BLND alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLND

    DatePrice TargetRatingAnalyst
    12/18/2024$7.00Mkt Outperform
    JMP Securities
    8/12/2024$3.00 → $4.75Hold → Buy
    Canaccord Genuity
    8/9/2024Mkt Perform → Outperform
    William Blair
    12/20/2023$1.50 → $3.50Equal Weight → Overweight
    Wells Fargo
    11/14/2022$2.25Underperform → Mkt Perform
    Keefe Bruyette
    7/25/2022$4.00 → $2.75Mkt Perform → Underperform
    Keefe Bruyette
    7/7/2022Overweight → Sector Weight
    KeyBanc Capital Markets
    5/25/2022$4.20Neutral
    Compass Point
    More analyst ratings